Innovative Approach: Sequestering Gut Bacteria's Microbial Fuel Improves Blood Sugar and Liver Health
New research reveals that trapping a microbial fuel from gut bacteria can significantly improve blood sugar control and liver health, opening new possibilities for treating metabolic diseases like diabetes and fatty liver disease.
Recent research from Canadian scientists has unveiled a groundbreaking method to enhance metabolic health by targeting a microbial-derived fuel in the gut. The study, published in Cell Metabolism, highlights how a molecule produced by gut microbiota can enter the bloodstream and promote excessive glucose and fat production in the liver, contributing to conditions like type 2 diabetes and fatty liver disease.
Researchers at McMaster University, Université Laval, and the University of Ottawa discovered that obese mice—and humans with obesity—exhibit elevated levels of D-lactate, a less common form of lactate originating primarily from gut bacteria. Unlike the well-known L-lactate produced by muscles, D-lactate was found to more aggressively raise blood sugar and liver fat.
The team developed a novel "gut substrate trap"—a biodegradable polymer that binds to D-lactate within the gut, preventing its absorption into the bloodstream. When administered to mice, this trap significantly lowered blood glucose levels, improved insulin sensitivity, and reduced liver inflammation and fibrosis—all without altering their diet or body weight.
Professor Jonathan Schertzer, the senior author, explained that this discovery introduces a new dimension to understanding metabolic pathways, extending the classic Cori cycle, which involves the exchange of lactate and glucose between muscles and the liver. This research reveals a new branch involving gut bacteria, adding complexity to how metabolic signals are mediated.
The findings are significant because they present a novel therapeutic target—intercepting the microbial fuel before it causes harm. This approach shifts the focus from hormonal or organ-specific treatments to the microbiome itself, highlighting its role in chronic metabolic diseases.
This research underscores the growing recognition of the microbiome's influence on health and disease, offering promising new avenues for managing obesity-related conditions.
For more detailed information, view the full study in Cell Metabolism: link. Source: Medical Xpress.
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
Impact of Federal Cuts on Language Services and Patient Safety Risks
Federal budget cuts are reducing language assistance services for non-English speakers, risking increased medical errors and disparities in healthcare access. Learn how policy changes affect patient safety and community health.
Advancing Global Diversity in Dementia Research for Better Outcomes
A global effort led by UNSW's CHeBA is revolutionizing dementia research by emphasizing diversity to develop more effective, inclusive prevention strategies worldwide. This initiative highlights critical regional differences in risk factors and promotes global collaboration to fight dementia.
RFK Jr. Forms Vaccination Panel Focused on Childhood Immunizations in Historic First Meeting
A new vaccination advisory panel appointed by RFK Jr. held its first meeting, raising questions about the childhood immunization schedule and discussing themes favored by anti-vaccine advocates, with potential implications for public health policy.
Unveiling the Hidden Complexity of Blood Cancer for Improved Treatments
New research uncovers the complex heterogeneity of mantle cell lymphoma, highlighting the need for personalized treatment strategies to improve outcomes and prevent relapse.